Evidence map›Paper›PMID 31199860›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2019

Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation.

Ellen Hoffmann, Florian Straube, Karl Wegscheider, Malte Kuniss, Dietrich Andresen, Li-Qun Wu, Jürgen Tebbenjohanns, Georg Noelker, Roland Richard Tilz, Julian Kyoung Ryul Chun and 10 more

Registry-linked trialOpen access · bronzeAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01360008 (FREEZE Cohort Study), which is not on this map. Cited by 65 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 3 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01360008 completednot on this map

FREEZE Cohort Study

TypeobservationalSponsorStiftung Institut fuer HerzinfarktforschungRan2011 to 2017Enrolled4,071ConditionsArrhythmia
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 3 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Esophageal injury, perforation, and fistula formation following atrial fibrillation ablation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Pooled it
  3. Comparison of cryoballoon and radiofrequency ablation for persistent atrial fibrillation: a systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023
    Pooled it
  4. Impact of cryoballoon application abortion due to phrenic nerve injury on reconnection rates: a YETI subgroup analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Trial
  5. Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 2 countries.

Ellen HoffmannDepartment of Cardiology and Internal Intensive Care Medicine, Heart Center Munich-Bogenhausen - Munich Municipal Hospital Group, Englschalkinger Str. 77, Munich, Germany.
Florian StraubeDepartment of Cardiology and Internal Intensive Care Medicine, Heart Center Munich-Bogenhausen - Munich Municipal Hospital Group, Englschalkinger Str. 77, Munich, Germany.
Karl WegscheiderDepartment of Medical Biometry and Epidemiology, University Medical Center Eppendorf, Hamburg, Germany.
Malte KunissDepartment of Cardiology, Kerckhoff Clinic, Bad Nauheim, Germany.
Dietrich AndresenDepartment of Cardiology at Evangelisches Krankenhaus Hubertus, Paul Gerhardt Diakonie gAG, Berlin, Germany.
Li-Qun WuDepartment of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Jürgen TebbenjohannsHELIOS Klinikum Hildesheim, Medizinische Klinik I - Kardiologie, Hildesheim, Germany.
Georg NoelkerDepartment of Cardiology, Herz-und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen, Germany.
Roland Richard TilzDepartment of Cardiology, Angiology, and Intensive Care Medicine, University Heart Centre Luebeck, University Hospital Schleswig-Holstein, Luebeck, Germany.
Julian Kyoung Ryul ChunCardioangiologisches Centrum Bethanien, Markus Krankenhaus, Frankfurt.
Andreas FrankeDepartment of Cardiology, KRH Klinikum Siloah-Oststadt-Heidehaus, Hannover, Germany.
Christoph StellbrinkDepartment of Cardiology, Klinikum Bielefeld, Germany.
Arcadi Garcia-AlberolaDepartment of Cardiology, University Hospital Virgen de la Arrixaca, El-Palmar, Murcia, Spain.
Uwe DorwarthDepartment of Cardiology and Internal Intensive Care Medicine, Heart Center Munich-Bogenhausen - Munich Municipal Hospital Group, Englschalkinger Str. 77, Munich, Germany.
Andreas MetznerDepartment of Cardiology, Asklepios Clinic St. Georg, Hamburg, Germany.
Taoufik OuarrakStiftung Institut fuer Herzinfarktforschung, Ludwigshafen, Germany.
Johannes BrachmannDepartment of Cardiology, REGIOMED Kliniken, Coburg, Germany.
Karl-Heinz KuckDepartment of Cardiology, Asklepios Clinic St. Georg, Hamburg, Germany.
Jochen SengesStiftung Institut fuer Herzinfarktforschung, Ludwigshafen, Germany.
FREEZE Cohort Study Investigators
München Klinik Bogenhausen · DEAsklepios Klinik St. Georg · DERegio Kliniken · DEStiftung Institut für Herzinfarktforschung · DEKlinikum Bielefeld · DEUniversität Hamburg · DEHeart and Diabetes Center North Rhine-Westphalia · DEHospital Universitario Virgen de la Arrixaca · ESKerckhoff Klinik · DEKlinikum Region Hannover · DEPaul Gerhardt Diakonie · DEUniversity of Hildesheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo evaluate the effectiveness and safety of cryoballoon ablation (CBA) compared with radiofrequency ablation (RFA) for symptomatic paroxysmal or drug-refractory persistent atrial fibrillation (AF). METHODS AND

resultsProspective cluster cohort study in experienced CBA and RFA centres. Primary endpoint was 'atrial arrhythmia recurrence', secondary endpoints were as follows: procedural results, safety, and clinical course. A total of 4189 patients were included: CBA 2329 (55.6%) and RFA 1860 (44.4%). Cryoballoon ablation population was younger, with fewer comorbidities. Procedure time was longer in the RFA group (P = 0.01). Radiation exposure was 2487 (CBA) and 1792 cGycm2 (RFA) (P < 0.001). Follow-up duration was 441 (CBA) and 511 days (RFA) (P < 0.0001). Primary endpoint occurred in 30.7% (CBA) and 39.4% patients (RFA) [adjusted hazard ratio (adjHR) 0.85, 95% confidence interval (CI) 0.70-1.04; P = 0.12). In paroxysmal AF, CBA resulted in a lower risk of recurrence (adjHR 0.80, 95% CI 0.64-0.99; P = 0.047). In persistent AF, the primary outcome was not different between groups. Major adverse cardiovascular and cerebrovascular event rates were 1.0% (CBA) and 2.8% (RFA) (adjHR 0.53, 95% CI 0.26-1.10; P = 0.088). Re-ablations (adjHR 0.46, 95% CI 0.34-0.61; P < 0.0001) and adverse events during follow-up (adjHR 0.64, 95% CI 0.48-0.88; P = 0.005) were less common after CBA. Higher rehospitalization rates with RFA were caused by re-ablations.

conclusionsThe primary endpoint did not differ between CBA and RFA. Cryoballoon ablation was completed rapidly; the radiation exposure was greater. Rehospitalization due to re-ablations and adverse events during follow-up were observed significantly less frequently after CBA than after RFA. Subgroup analysis suggested a lower risk of recurrence after CBA in paroxysmal AF.

trial registrationClinicalTrials.gov (NCT01360008), https://clinicaltrials.gov/ct2/show/NCT01360008.

Indexed as

AgedAtrial FibrillationCatheter AblationCohort StudiesCryosurgeryFemaleHumansMaleMiddle AgedOperative TimePatient ReadmissionPostoperative ComplicationsProportional Hazards ModelsProspective StudiesRadiation DosageRecurrenceAtrial fibrillationCatheter ablationCryoballoonParoxysmalPersistentRadiofrequency

Identifiers

PMID31199860
PMCPMC6735953
OpenAlexW2952635553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.